Home > NRC Library > ADAMS Public Documents

Record of 840813 telcon w/J Day re amends to Licenses SNM-1369,37-00467-34 & 37-00467-35 to reflect name & address change.

Accession Number: ML20209A658

Date Released: Tuesday, October 29, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20212Q760 - Record of 840813 telcon w/J Day re amends to Licenses SNM-1369,37-00467-34 & 37-00467-35 to reflect name & address change. (1 page(s), 8/13/1984)
• ML20212Q793 - Confirms 840316 telcon.NRC policy to approve cardiologists to use byproduct matls for nuclear cardiology based on 200 h basic didactic training & 500 h clinical training in nuclear cardiology only. (1 page(s), 3/22/1984)
• ML20212Q812 - Forwards Amend 11 to License 37-00467-34.Records of 831028, 840131 & 0201 telcons & 831107 technical assistance request encl. (6 page(s), 2/7/1984)
• ML20212Q840 - Approves encl application for amend to License 37-00467-34, authorizing transport of Ru-106/Rh-106 opthamalic applicators for treatment of ocular tumors.Fee paid. (1 page(s), 10/10/1983)
• ML20212Q854 - Application for amend to License 37-00467-34,authorizing transport of Ru-106/Rh-106 opthamalic applicators for treatment of ocular tumors.Activity per plaque will not exceed 0.6 mCi. (1 page(s), 10/10/1983)
• ML20212Q862 - Forwards Amend 10 to License 37-00467-34. (1 page(s), 3/4/1983)
• ML20212Q872 - Notifies that unless response to NRC 821221 request for addl info re 821115 application for amend to License 37-00467-34 received within 30 days,application will be considered abandoned w/o prejudice to resubmission. (1 page(s), 1/24/1983)
• ML20212Q971 - Forwards addl info re application for use of Ru-106 opthamalic applicators at Wills Eye Hosp.Mfg description of const & characteristics of applicators,nonprofessional translations of German matl & article reprints encl. (15 page(s), 10/28/1983)
• ML20212Q981 - "Techniques & Results of Ru-106/Rh-106 Radiation of Choroidal Tumors." (6 page(s), 12/31/1983)
• ML20212Q993 - "Experience W/Beta-Irradiation (Ru-106/Rh-106) of Patients Suffering From Retinoblastoma (Rept on 33 Patients)." (7 page(s), 12/31/1978)
• ML20212Q998 - "Beta-Irradiation of Retinoblastoma W/Ru-106/Rh-106 Applicators." (9 page(s), 12/31/1977)
• ML20212R010 - "Treatment of Choroidal Melanomas W/Ru-106/Rh-106 Beta-Ray Applicators." (16 page(s), 12/31/1974)
• ML20212R023 - Submits addl info re application for amend to License 37-00467-34.Max acceptable radiation levels in unrestricted area following implants 200 mrem in any consecutive 7 days, w/no nonradioactive patient receiving more than 200 mrem. (11 page(s), 2/16/1983)
• ML20212R027 - Requests addl info including confirmation that data submitted represents max radiation levels in each unrestricted area & nonpatient occupancy factors,to complete review of 821115 request to exceed limits in 10CFR20.105(a). (2 page(s), 12/21/1982)
• ML20212R033 - Forwards Amend 9,renewing License 37-00467-34. (1 page(s), 4/14/1982)
• ML20212R041 - Forwards "Model Program for Maintaining Occupational Radiation Exposures at Medical Institutions ALARA," re application for renewal of License 37-00467-34. (1 page(s), 3/23/1982)
• ML20212R052 - "Model Program for Maintaining Occupational Radiation Exposures at Medical Institutions ALARA,Hahnemann Medical College & Hosp." (4 page(s), 3/22/1982)
• ML20212R071 - Requests addl info re 790323 application to renew License 37-00467-34,including membership of radiation control committee,description of duties & responsibilities of radiation safety officer & description of training. (3 page(s), 12/17/1981)
• ML20212R079 - Application for license to use 285 lb depleted U as shielding in Varian Assoc linear accelerator.U-235 content reduced to less than 0.2%.All pieces cadmium-plated to to prevent oxidation & stamped w/caution notice. (1 page(s), 11/24/1981)
• ML20212R096 - Forwards Amend 8 to License 37-00467-34,per 810511 request. License incorporates model ALARA program.Alternative program may be submitted for further license amend. (1 page(s), 9/22/1981)
• ML20212R102 - Advises that Condition 27 of license permits transportation of licensed matls by Hahnemann personnel.Verification of authorization of recipients to receive licensed matl required.Receiving hosps may need to amend licenses. (1 page(s), 8/7/1981)
• ML20212R110 - Clarifies interpretation of Condition 27 of License 37-00467-34 re understanding that condition allows transport of licensed matls to & from hosps if hosps licensed to receive matls. (2 page(s), 6/1/1981)
• ML20209A654 - Forwards application for renewal of License 37-00467-34.Addl info encl. (1 page(s), 3/19/1979)
• ML20209A662 - Application for renewal of License 37-00467-34 to authorize use of any byproduct matl w/Atomic Numbers 3-83 for medical research,diagnosis & therapy. (108 page(s), 3/23/1979)